| Structure |
Chemical Name |
CAS |
MF |
 |
O-Desethyl N-Trityl Candesartan Cilexetil |
934495-65-5 |
C50H44N6O6 |
 |
5-ForMyl-8-hydroxycarbostyril |
68304-21-2 |
C10H7NO3 |
 |
Capecitabine Related Compound A |
|
|
![5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-chloro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-](/CAS/20210305/GIF/2212021-92-4.gif) |
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-chloro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- |
2212021-92-4 |
C20H27ClN4O2 |
 |
1-Pyrrolidineaceticacid,2-(aminocarbonyl)-,(2S)-(9CI) |
277751-02-7 |
C7H12N2O3 |
 |
2-Pyrrolidinecarbonitrile,1-acetyl-,(2S)-(9CI) |
700376-84-7 |
C7H10N2O |
 |
1-Azetidinesulfonamide(9CI) |
654073-32-2 |
C3H8N2O2S |
 |
1-Piperazinecarboxylicacid,4-methyl-,ethylester(6CI,9CI) |
59325-11-0 |
C8H16N2O2 |
 |
(1S,4R)-4-Amino-2-cyclopenten-1-carboxylic Acid Hydrochloride |
134234-04-1 |
C6H9NO2 |
 |
erythronolide B |
3225-82-9 |
C21H38O7 |
 |
N-nitrosospermidine |
78249-62-4 |
C7H18N4O |
 |
desmethylmianserin |
71936-92-0 |
C17H18N2 |
 |
3-demethylthiocolchicine |
87424-25-7 |
C21H23NO5S |
 |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone |
2607-52-5 |
C15H22O |
|
|
Biapenem Impurity B |
|
|
|
|
Finerenone-d5 |
|
|
 |
2-acetyl-2-decarboxamidooxytetracycline |
6542-44-5 |
C23H25NO8 |
 |
7,8-dehydro-9,10-desacetyldoxorubicinone |
64845-67-6 |
C19H12O6 |
|
|
Tafluprost Impurity 17 |
|
|
|
|
Rosuvastatin Impurity 160 （Sodium salt) |
|
|
 |
Rosuvastatin Impurity 143 |
2964549-48-0 |
C32H34F2N6O7S2 |
|
|
Rosuvastatin Impurity 131 |
|
|
|
|
Rosuvastatin Impurity 125 |
|
|
|
|
Metabotropic glutamate receptor 5 (GRM5) Antibody |
|
|
|
|
Terlipressin Impurity 2 (des-Gly1,Gly2) |
|
|
![BENZHYDRYL 6,6-DIHYDROPENICILLIC ACID 1-OXIDE[TAZOBACTAM INTERMEDIATE]](/CAS/20180713/GIF/87579-78-0.gif) |
BENZHYDRYL 6,6-DIHYDROPENICILLIC ACID 1-OXIDE[TAZOBACTAM INTERMEDIATE] |
87579-78-0 |
C21H21NO4S |
|
|
4-(2-((2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)thiazol-4-yl)benzamide |
|
|
|
|
Ertapenem Impurity C(USP) |
|
|
|
|
Ertapenem Impurity 22 |
|
|
|
|
(1-carboxy-1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)ethyl)-L-cysteine |
|
|
 |
Pyrazinecarboxylic acid, 5-methyl-, 1-oxide (9CI) |
98502-96-6 |
C6H6N2O3 |
 |
1,4-Butanediaminium, N1,N4-diethyl-N1,N1,N4,N4-tetrakis(1-methylethyl)-, bromide (1:2) |
1621467-18-2 |
C20H46BrN2+ |
 |
1,6,10,14-Hexadecatetraen-3-ol, 3,7,11,15-tetramethyl-, (6Z,10E)- |
3790-76-9 |
C20H34O |
|
|
Bisoprolol Impurity 51 |
|
|
 |
2-Deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate-1-methanesulfonate |
134877-42-2 |
C20H18F2O8S |
|
|
Pitavastatin Impurity 105 |
|
|
|
|
Nirmatrelvir Impurity 11 |
|
|
|
|
Bumetanide Impurity 21 |
|
|
|
|
Amoxicillin related impurities K |
|
|
|
|
Amoxicillin related impurities K |
|
|
![4'-(Hydroxymethyl)-[1,1'-Biphenyl]-2-Carboxylic Acid](/CAS/GIF/158144-54-8.gif) |
4'-(Hydroxymethyl)-[1,1'-Biphenyl]-2-Carboxylic Acid |
158144-54-8 |
C14H12O3 |
|
|
Brivaracetam Impurity 118 |
|
|
 |
1-(4-((2-(4-hydroxypiperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxylic acid |
2975124-11-7 |
C22H34N4O3 |
|
|
Empagliflozin Impurity 108 |
|
|
|
|
Perospirone Impurity 28 |
|
|
|
|
Perospirone Impurity 23 |
|
|
|
|
Perospirone Impurity 16 |
|
|
|
|
Dolutegravir Impurity 24 |
|
|
|
|
Paxlovid Impurity 18 |
|
|
|
|
Related impurities of fluoxetine sodium 8 |
|
|
|
|
Fondaparinux sodium impurity 15 |
|
|
|
|
Fondaparinux Sodium Impurity 10 |
|
|
|
|
Oxacillin sodium Impurity E |
|
|
|
|
ltrombopag Impurity 26 |
|
|
|
|
Revefenacin Impurity 19 |
|
|
|
|
Caspofungin Impurity 11 |
|
|
|
|
Miglitol Isomer ImpurityA |
|
|
![Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-β-oxo-, ethyl ester, (αZ)-](/CAS/20210305/GIF/951313-24-9.gif) |
Benzenepropanoic acid, α-[(cyclopropylamino)methylene]-2,4-difluoro-3-methoxy-β-oxo-, ethyl ester, (αZ)- |
951313-24-9 |
C16H17F2NO4 |
|
|
sodium (6R,7S)-7-(2-mercaptoacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
|
Olodaterol Impurity 33 |
|
|
 |
1H-Benzimidazol-2-amine, 5,6-dichloro-N-(1-methylethyl)-1-α-L-ribofuranosyl- |
176161-49-2 |
C15H19Cl2N3O4 |
 |
(1R,4S)-N-Desmethyl Sertraline Hydrochloride |
675126-08-6 |
C16H15Cl2N.ClH |
 |
3-(4-Formylaminobutyryl)pyridine |
887355-56-8 |
C10H12N2O2 |
 |
Didesmethyl Erlotinib Hydrochloride Salt |
183320-12-9 |
C20H20ClN3O4 |
|
|
Linagliptin Impurity L |
|
|
 |
Linagliptin Impurity S |
668273-74-3 |
C30H36N8O4 |
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
|
C17H18FN5O2 |
 |
Olaparib impurity 1 |
763113-06-0 |
C24H24N4O3 |
 |
4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1) |
1624294-38-7 |
C22H26ClN3O4 |
 |
4-Oxiranylmethoxy-benzaldehyde |
14697-49-5 |
C10H10O3 |
 |
Alogliptin Related Compound 24 |
1430222-06-2 |
C14H12ClN3O2 |
|
|
Apremilast Impurity 1 |
|
|
 |
Etoricoxib Impurity 15 |
73312-69-3 |
C5H8ClNO |
|
|
Ibrutinib Impurity 1 |
|
|
|
|
Mirabegron Impurity 13 |
|
|
|
|
Riociguat Impurtiy 4 |
|
|
 |
2,3-Dehydrosilybin B |
142796-24-5 |
C25H20O10 |
 |
Cabozantinib Impurity |
1355031-15-0 |
C16H14N2O3 |
|
|
Canagliflozin open-ring impurity |
|
|
|
|
Dapoxetine Impurity E |
|
|
 |
Ilaprazole Impurity |
1018229-53-2 |
C11H9N3O |
|
|
Linagliptin Impurity X |
|
|
 |
Norfloxacin Imp.(EP) |
1911573-08-4 |
C34H52FN3O4 |
 |
Rocuronium Bromide Impurity |
13492-57-4 |
C27H44N2O4 |
|
|
Ruxolitinib Impurity |
|
|
|
|
Roxithromycin h |
|
|
|
|
Ixazomib Impurity 2 |
|
|
 |
sildenafil impurity I |
|
C22H30N6O4S |
![2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni](/CAS/GIF/120511-92-4.gif) |
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni |
120511-92-4 |
C17H19N5 |
|
|
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni |
120511-92-4 |
C17H19N5 |
![4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180629/GIF/942195-83-7.gif) |
4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
942195-83-7 |
C16H14N2O3 |
|
|
Tofacitinib Impurity G |
|
|
 |
Ceftaroline Fosamil Impurity 6 |
953037-71-3 |
C22H20N8O5S4 |
 |
Zolmitriptan Related Compound F |
1350928-05-0 |
C38H53N7O4 |
![4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol](/CAS/20180629/GIF/913614-15-0.gif) |
4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol |
913614-15-0 |
C16H22N2OS |
 |
3-((methoxycarbonyl)methyl)-5-methylhexanoic acid |
181289-11-2 |
C10H18O4 |
 |
Cyanocobalamin Impurity F |
23208-66-4 |
C63H85CoN13O15P |
|
|
Acarbose Impurity D |
|
|
|
|
Acarbose Impurity D |
|
|
|
|
Acarbose Impurity C |
|
|